A National Seminar on Evolving Concepts in Stem Cells and Regenerative Medicine
27th February, 2014
Online Registration will be closed at 17:00 pm on 25th February 2014.
Spot registration will be done on 27th February 2014 as per the availability.
Organized By
BIT Virtual Bioinformatics Node(GCRI)
Dept. of Cancer Biology
The Gujarat Cancer & Research Institute
New Civil Hospital Campus, Asarwa,
Ahmedabad, GUJARAT
e-mail: bioconclave@gmail.com
Venue:
CAMA HALL, The Gujarat Cancer & Research Institute,
New Civil Hospital Campus, Asarwa, Ahmedabad-16
Theme EVOLVING CONCEPTS IN STEM CELLS AND REGENERATIVE MEDICINE
Stem cells have the propensity to produce tissue, an attribute that not only contributes to normal human development but also to compensate the degenerated tissue caused due to injury or disease. The typical characteristics e.g. division, differentiation and plasticity has generated widespread interest in stem (and progenitor) cells and their potential to treat and cure human diseases in the emerging field of regenerative medicine. Great expectations and desperate hope for immediate clinical application have driven intense debates at the national and international level to establish guidelines for isolation, expansion and manipulation of stem cells for therapeutic purpose. The situation has also prompted patients all over the world to think rationally before seeking alternative and usually unproven stem cell “therapies” that can put them at risk. These challenges justify support for more science that must include both in-vitro and in-vivo studies of stem/progenitor cells from a variety of tissues and organs.
The rapid pace of stem cell biology and regenerative medicine moving toward translation to clinical practice has become more dependent on donors and hosts for generating cellular reagents and assaying their potential therapeutic efficacy in human disease. Advances in cell culture technologies have revealed a remarkable plasticity of stem cells from embryonic and adult tissues, and transplantation models are now needed to test the ability of these cells to protect at-risk cells and replace cells lost to injury or disease. Progress from the use of both in-vitro and in-vivo regenerative medicine models already offers hope both the use of stem cells as powerful new therapeutic reagents for cancer and other challenging human diseases. Thus exploring these novel models and concepts can set a new paradigm in the field of regenerative medicine and drug discovery.
FOCUS AREA:
STEM CELL & REGENERATIVE MEDICINE
In-silico prediction of Stem cell differentiation
In-vitro Stem cell model in Drug discovery
In-vivo Stem cell model in drug discovery
Nano technology & Stem cell therapeutics
Induced pluripotency
Invited Faculties
Dr. Vipin Kumar, Director NIF, Ahmedabad
Dr. Gopal Kundu, NCCS, Pune
Dr. Dhananjay Tiwary, DBT, New Delhi
Who Should Participate
Graduate and Postgraduate students of Biological Sciences
Research Scholars in Biological Sciences
Faculties in Biological Sciences
Scientists from Academia and Industries
Participation: Attend/Present Poster
Fee:
200/- (Academic)
500/-(Corporate/Industry)
Contact:
Organizing Secretary
Dr. Rakesh M Rawal
9925244855 ; 9925103733 ; 9601288506
mail id : bioconclave@gmail.com
0 Comments